Delivery Order SPE2DB22D2206-SPE2DB25FJK75
Award Date 8/14/25
Potential Completion Date 8/15/25
Potential Value $3.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $8,127.12 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Meropenem 0.9% sodium chloride (1 gram/50 mL) pharmaceutical product. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and represents a non-competitive award. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,434.58 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50 units. This competitively awarded, firm fixed-price contract is set to be completed by August 11, 2025, with performance taking place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a child delivery order issued under a larger vehicle, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $7,365.36 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50s, a broad-spectrum antibiotic used in military and federal healthcare settings. The award, issued on August 14, 2025, with completion targeted for August 15, 2025, utilizes firm fixed pricing under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performance...
- The Defense Logistics Agency awarded a delivery order valued at $4,175.33 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50s, a critical antibiotic medication. This firm fixed-price, competitively awarded delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The pharmaceuticals will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations....
- The Defense Logistics Agency awarded a delivery order valued at $1,317.62 to AmerisourceBergen Drug Corp for the supply of Meropenem 2 gram vials, an antibiotic pharmaceutical product. The contract was awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, using firm fixed price terms without any set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,625.71, is for the supply of MEROPENEM-0.9% NACL 1 GRAM/50S, a pharmaceutical product. The contract has an ultimate completion date of January 3, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,940.78 firm fixed-price delivery order is for the supply of Meropenem 2 gram vials, a critical antibiotic medication. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of 4,563,697,433 units of the pharmaceutical drug meropenem, a 2 gram vial. The contract has a total potential value of $2,440.78 and a completion date of February 20, 2024. This delivery order contract is not...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Meropenem IV 1 GM vials. The $1,096.83 firm fixed-price delivery order is not associated with a set-aside requirement. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to deliver a comprehensive range of...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,269.70 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, for the supply of Ertapenem 1 gram vials. This competitively awarded, firm fixed-price contract has an ultimate completion date of July 22, 2025, and represents a small-value pharmaceutical procurement with no set-aside designation. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...